📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells. (2016)

First Author: Delgado-Goni T

Attributed to: Multimodality Techniques for Cancer Diagnosis and Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-16-0068

PubMed Identifier: 27765851

Publication URI: http://europepmc.org/abstract/MED/27765851

Type: Journal Article/Review

Volume: 15

Parent Publication: Molecular cancer therapeutics

Issue: 12

ISSN: 1535-7163